CDC, FDA recommend US pause use of Johnson & Johnson’s COVID-19 vaccine over blood clot concerns

The FDA and the Facilities for Illness Management and Prevention are reviewing studies of uncommon and extreme blood clots from six individuals who acquired the vaccine.